Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity

Details for Australian Patent Application No. 2010286496 (hide)

Owner Immunomedics, Inc. IBC Pharmaceuticals, Inc.

Inventors Chang, Chien-Hsing; Goldenberg, David M.; Rossi, Edmund A.

Agent Davies Collison Cave

Pub. Number AU-A-2010286496

PCT Pub. Number WO2011/026026

Priority 61/238,473 31.08.09 US; 12/752,649 01.04.10 US; 61/266,305 03.12.09 US; 12/644,146 22.12.09 US; 12/754,140 05.04.10 US; 12/754,740 06.04.10 US; 61/316,996 24.03.10 US; 12/731,781 25.03.10 US; 61/323,960 14.04.10 US

Filing date 30 August 2010

Wipo publication date 3 March 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/026026 Priority application(s): WO2011/026026

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010286499-Compact automated cell counter

2010286482-Locking access plug for a bar gun